Ativo Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Ativo Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-125,032	Closed	-$1.48M	–	252
2017 Q3	$1.48M	Sell	125,032 -13,000	-9%	-$146K	0.4%	89
2017 Q2	$1.45M	Buy	138,032 +29,009	+27%	+$296K	0.4%	86
2017 Q1	$1.2M	Hold	109,023	–	–	0.3%	125
2016 Q4	$1.48M	Buy	109,023 +17,000	+18%	+$237K	0.35%	93
2016 Q3	$1.13M	Hold	92,023	–	–	0.26%	129
2016 Q2	$1.01M	Buy	+92,023	New	+$1.03M	0.25%	128

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Ativo Capital Management's SCMP Position: Q4 2017 in Review

Ativo Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 125,032 shares — an estimated $1.48M sold.

Ativo Capital Management first reported a position in SCMP in Q2 2016 and held it in 6 quarters. The position peaked at $1.48M in Q4 2016. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Ativo Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Ativo Capital Management sold 125,032 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $1.48M.
Ativo Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 6 quarters.
Ativo Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.48M in Q4 2016.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Ativo Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.